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Abstract 
Objective: To evaluate a role of apparent diffusion coefficient (ADC) values measured from diffusion-weighted imag-
ing we investigated its association with clinicopathological tumor characteristics of bladder cancer.
Materials and methods: Diffusion-weighted MRI at 1.5 Tesla using b-values of 0, 1000 s/mm2 was taken before 
transurethral resection by 114 bladder urothelial tumor patients. ADC value was measured and its relationship with 
pathological factors including T stage, tumor grade, infiltration style (INF) and lymphatic invasion (ly) was analyzed.
Results: Median ADC value was significantly lower in Grade 3 than in Grade 1 (P < 0.001) or in Grade 2 (P = 0.002), in 
INFb than in INFa (P = 0.004), in INFc than in INFa (P < 0.001), in ly1 than in ly0 (P < 0.001) and lower in T2≦ than in T1≧ 
(P < 0.001), respectively. Receiver operating curve demonstrated the accuracy of detecting muscle invasive bladder 
cancer or ly+ by using area under curve (AUC), showing 0.758 and 0.748.
Conclusion: ADC value is likely to serve as a useful biomarker showing clinicopathological characterictics of bladder 
cancer.
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Background
Bladder cancer is the most common malignancy involv-
ing the urological field (Torre et  al. 2015). Ultrasonog-
raphy, computed tomography (CT), and cystoscopy are 
commonly available for detection of bladder cancer, but 
are not accurate enough to illustrate histological char-
acteristics, for example, histological grade and tumor 
stage, which has relationship to recurrence and progres-
sion (Sylvester et al. 2006). Diffusion-weighted (DW) MR 
imaging is helpful to the diagnosis of malignant tumors 
and an apparent diffusion coefficient (ADC) can reflect 
tumor characteristics (Takeuchi et al. 2009). ADC value 
of bladder cancer was lower than that of normal blad-
der wall and could reflect histological grade and T stage. 
In addition to these two histological factors, we evalu-
ated whether the two other histological factors, that is, 
infiltration style (INF) and lymphatic invasion (ly), had 
significant association with ADC value in bladder can-
cer. Especially ly is proved to predict not only local and 
distant recurrence but also adverse overall and disease-
specific survival, independent of histological grade and 
T stage (Lotan et al. 2005). Besides, addition ly to other 
clinical parameters to nomogram assessing cancer sur-
vival or recurrence showed better prediction than TNM 
classification (Shariat et  al. 2010). The purpose of this 
study was to assess the utility of preoperative ADC value 
illustrating these four clinico-histological factors, which 
affect treatment decision and predict metastasis and 
recurrence of bladder cancer.
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Results
The patients and tumor characteristics are shown in 
Table  1. Of the 126 patients, 114 had urothelial carci-
noma and 9 had the other malignancies; 2 adenocar-
cinomas, 2 malignant lymphomas, 1 signet ring cell 
carcinoma, 1 small cell carcinoma, 1 urachal carcinoma, 
1 sigmoid carcinoma and 1 undifferentiated carcinoma.
In the 3 patients with a benign lesion, all were diag-
nosed as erosive cystitis.
We only statistically analyzed tumor characteristics of 
urothelial carcinoma.
To investigate whether ADC values in DW-MRI reflect 
quantitative information on the clinical aggressiveness of 
bladder cancer, we compared ADC values according to 
several histologic factors in Fig. 1a–d.
The median ADCs of Grade 1, Grade 2, and Grade 3 
tumors were 1.41 × 10−3 mm2/s, 1.15 × 10−3 mm2/s, and 
0.74 × 10−3 mm2/s, respectively. The differences in ADC 
were significant between Grade 1 and Grade 3 (P < 0.001) 
and between Grade 2 and Grade 3 (P = 0.002).
The median ADCs of INFa, INFb, and INFc tumors 
were 1.28  ×  10−3  mm2/s, 0.75  ×  10−3  mm2/s, and 
0.64 × 10−3 mm2/s, respectively. The differences in ADC 
were significant between INFa and INFb (P = 0.004) and 
between INFa and INFc (P < 0.001).
The median ADCs of ly0 and ly1 were 1.20 × 10−3 mm2/s 
and 0.74  ×  10−3  mm2/s, respectively. The differences in 
ADC were significant between ly0 and ly1 (P < 0.001).
The median ADCs of T1≧ and T2≦ were 
1.08 × 10−3 mm2/s and 0.71 × 10−3 mm2/s, respectively. 
The differences in ADC were significant between T1≧ 
and T2≦ (P < 0.001).
Diagnostic performance of ADC values in differentiat-
ing not only MIBC and NMIBC but also ly+ and ly− are 
shown in Fig. 2a, b.
The cut-off value in the receiver operating char-
acteristic (ROC) curve for differentiating MIBC and 
NMIBC according to ADC values was found to be 
0.89 × 10−3mm2/s, of which area under curve (AUC) was 
0.758. Based on these values, the sensitivity was 68.8  % 
and the specificity was 84.4 %. The value for differentiat-
ing ly+ versus ly− according to ADC values was found to 
be 1.11 × 10−3 mm2/s, of which AUC was 0.747. Based 
on these values, the sensitivity was 56.4 % and the speci-
ficity was 84.8 %.
Discussion
Diffusion illustrates the random motion of water mol-
ecules in the tissue, which is called “Brownian motion”. 
Currently from DW images the measurement of ADC 
values can be the quantitative assessment for this phe-
nomenon. Malignancies tend to include a larger cell 
diameter, higher cellularity than normal tissue. Therefore 
water diffusion is disturbed, which lead to lower ADC 
value (Padhani et  al. 2009). ADC value provided us to 
qualitative evaluation of malignant tissues.
ADC value of bladder cancer was lower than that 
of normal bladder tissue. The mean ADC value of G3 
tumors was significantly lower than that of either G1 or 
G2 tumors, and all G3 tumors showed an ADC value 
less than 1.0 × 10−3 mm2/s (Takeuchi et al. 2009), which 
was almost compatible to our results. Tumor grade is 
influenced by several pathological factors reflecting on 
cellular density, the ADC value can predict the histo-
logic grade of bladder cancer. Besides, though our result 
did not show significant difference between G1 and G2 
tumor, ADC value of G3 tumor was lower than that of 
both G1 and G2. Whether tumor include G3 component 
or not affects following treatment, because G3 tumor in 
NMIBC often requires additional treatment; not only 
intravesical instillation of anti-cancer drug or BCG but 
Table 1 Patients and tumor characteristics
* Median (range); # Pathological T stage was determined by examining TUR 
specimens
Variable Number




Tumor size (mm) 20.5 (5–84)*
No. Cancers 2 (1–10)
TNM stage
 T category#
  Tis 4
  Ta 40
  T1 39








 Grade 1 9
 Grade 2 48
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also second look TUR, in case of NMIBC, therefore ADC 
value can be a preoperative helpful tool predicting fol-
lowing treatment. Histological grade and T stage affected 
cancer-specific survival in bladder cancer (Sugahara et al. 
1999), therefore preoperative quantitative assessment of 
ADC value may predict survival benefit and avoid unnec-
essary procedure in bladder cancer.
INF illustrates the style of tumor infiltration to deep 
layer of bladder and ly demonstrates tumor invasion to 
lymph vessel. Both histologic factors have relationship to 
tumor aggressiveness and potential of metastasis or inva-
sion to adjacent organ. Infiltration of the vascular and/or 
lymphatic structures by tumor cells is an essential pro-
cess in tumor dissemination (Padera et  al. 2002; Alitalo 
et al. 2004; Kikuchi et al. 2009; Akao et al. 2008). Malig-
nant cells invade the lymphovascular space, proliferate, 
and then permeate the local lymphatics or spread more 
widely (Alexander-Sefre et  al. 2003). Lymphatic inva-
sion is independently associated with overall survival, 
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Fig. 1 An association of ADC values with, a T stage, b histological grade, c infiltration type (INF) and d lymphatic invasion (ly). Boxplots demonstrate 
the distribution of ADC values according to the T stage, histological grade, INF and ly. The middle line in each box represents the median, while the 
lower and upper boundaries of the boxes represent lower and upper quartiles (25th and 75th percentiles, respectively)
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in patients with negative lymph nodes at radical cystec-
tomy (Lotan et  al. 2005; Kim et  al. 2014). The current 
study demonstrated that lower ADC value was related to 
stronger degree of tumor infiltration and the presence of 
lymphatic invasion. Unfortunately our study didn’t show 
lower ADC value was directly related to survival or meta-
static risk (data not shown), but ADC value may predict 
survival or metastatic risk if more data is accumulated. 
Although our result demonstrated that INFb was not sig-
nificantly higher than INFc because of pathological dif-
ficulty in discrimination between INFb and INFc. But it 
has to be cautioned that more advanced T stage, higher 
grade, stronger infiltration and lymphatic invasion may 
express the phenomenon of tumor aggressiveness simul-
taneously. A prospective validation study is awaited in 
order to assess availability of measuring ADC value in 
predicting tumor aggressiveness.
Our study have several numbers of limitation. First, 
inflammatory changes before MR imaging might affect 
ADC evaluation in some cases (Barentsz et  al. 1996), 
because inflammatory cells disturbe water molecule’s 
diffusion. Second, all the radiologic result did not match 
pathologic result because we could not identify all the 
cut surfaces on surgical specimens which was seen on 
MR images. Besides specimen derived from TUR were 
cut into small pieces, which lead to make evaluation of 
INF or ly more difficult. Third, ADC value is reflected on 
MRI parameters including the coil systems, scanning sys-
tems, FOV, repetition time, echo time, matrix, b-values 
and many other parameters (Sasaki et al. 2008), therefore 
cut-off ADC value determined in our study may not suit-
able at the other institutional imaging protocols. In order 
to revise the difference, relative parameters, such as ADC 
ratios, calculated as ADC value in tumor/ADC value in 
adjacent structures (normal bladder wall or obturator 
internus muscle), would be more reliable in case of com-
parison among different institution. Finally, there may 
be selection bias in this study. Small or flat tumors like 
carcinoma in situ, which were undetectable on MRI were 
eliminated from current study. DW imaging requires 
enough space for assessment, compared with normal 
MRI imaging.
Conclusion
Our results demonstrated that DW imaging with ADC 
measurement is reliable method for clinicopathological 
tumor aggressiveness of bladder. In addition ADC value 
may supplement other currently applied parameters for 
predicting tumor behavior and making treatment deci-
sions. However, further studies with larger series are 
needed to validate a more efficient use of this technique 
and a wider clinical application.
Methods
Patients
Our hospital’s institutional review board approved this 
study. The requirement for patients’ informed consent 
was waived for this retrospective study.
Between April 2009 and November 2013, 126 patients 
with cystoscopy-proven bladder tumors underwent MRI, 
including both DW-MRI and T2-weighted magnetic 
Fig. 2 a Receiver operating curve (ROC) showed an area under curve 
(AUC) of 0.758 for predicting muscle invasive bladder cancer (ADC 
0.89 × 10−3 mm2/s; sensitivity 68.8 %, specificity 84.4 %). b 0.747 for 
predicting lymphvascular invasion (ly+) (ADC 1.11 × 10−3 mm2/s; 
sensitivity 56.4 %, specificity 84.8 %)
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resonance imaging (T2W-MRI) protocols, before tran-
surethral resection in a retrospective study investigating 
the potential role of DW-MRI and/or ADC value as a 
biomarker for bladder cancer. Patients with histologically 
confirmed bladder cancer were eligible for analysis.
Imaging protocol
Multi-sequence MRI was carried out with a 1.5-Tesla 
imager (Toshiba, Japan) under free breathing with 
4-channel sensitivity encoding body coil after a 4–6  h 
fast and voiding 1  h before the examination. The imag-
ing parameters for DW-MRI with single-shot echo pla-
nar imaging sequence were set as follows: repetition 
time, 8000 ms; echo time, 80 ms; matrix, 128 × 128; field 
of view, 38  cm; acquisition time, 220  s; slice thickness, 
5 mm; interslice gap, 0.5 mm; number of slices, 24; num-
ber of excitations, 8; bandwidth, 1302 Hz per pixel; two 
different diffusion gradient b-values (b = 0, 1000 s/mm2); 
fat suppression, spectral pre-saturation inversion recov-
ery. T2W-MRI, the parameters were set as follows: repe-
tition time, 4000 ms; echo time, 90 ms; matrix, 256 × 38; 
field of view, 20 cm; acquisition time, 180  s; slice thick-
ness, 4 mm; interslice gap, 0.4 mm; number of slices; 24; 
number of excitations, 3; bandwidth, 122 Hz per pixel.
Detection of bladder cancer by DW‑MRI and T2 W‑MRI
Detection of bladder cancer on MRI was defined as a 
mass with high signal intensity (SI) arising in the normal 
bladder wall with low SI (Fig. 3).
All image sets of DW-MRI and T2W-MRI were inde-
pendently reviewed by two radiologists (I.M., I.H.; both 
have 20  years of experience, respectively) who were 
blinded to the TUR and histopathological findings. The 
reviewer assessed intravesical tumor location and T stage 
by reviewing images on transverse planes. Patients with 
hypersignal lesions with a b-value of 1000  s/mm2 on 
DW-MRI or those showing mass formation on T2W-
MRI were diagnosed with bladder cancer.
TUR findings
The numbers, sizes (maximum diameter), and intravesi-
cal locations of bladder tumors were recorded.
TNM classification
Nodal and metastatic evaluation was performed accord-
ing to TNM Classification of Malignant tumours 7th 
edition.
Histopathological findings
Histological grade, lymphatic invasion, vessel invasion, 
schirrous change and pathological T stage were deter-
mined according to the 2004 World Health Organi-
zation/International Society of Urological Pathology 
Fig. 3 MR images of 80-year-old man with histologically confirmed 
muscle-invasive bladder tumor (MIBC). a Tumor shows the thickened 
muscle layer focally disrupted on transverse T2WMRI. b Tumor shows 
high intensity area without submocosal components on transverse 
DW-MRI (b; 0, 1000 s/mm2). c ADC values or tumor, measured within 
an ROI is 0.94 × 10−3 mm2/s
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classification and the 2009 TNM system, respectively. 
In patients with multiple tumors, each patient’s T stage 
and histological grade reflects the conditions of that 
patient’s highest-stage index tumor. Tumors were classi-
fied into three grades: G1, the least degree of anaplasia; 
G2, an intermediate degree of anaplasia: and G3, severe 
anapalsia. Histological invasion form was also classified 
into three forms: INFa, tumor growth shows expand-
ingly and tumor is clearly divided between benign tissue; 
INFb, tumor shows intermediate growth between INFa 
and INFc: INFc, tumor invasion in the deepest point 
shows cellularity or in micronodule form. A pathologist 
with 30-year of experience in urogenital pathology was 
responsible for performing all pathological examinations.
ADC measurement
To quantitatively analyze the degree of diffusion, ADC 
values were calculated in tumors correctly detected by 
two radiologists on DW-MRI. ADC maps of lesions were 
reconstructed with the two different diffusion gradi-
ent b-values at a workstation (Toshiba, Japan). Regions 
of interests (ROIs), maximally covering but not extend-
ing beyond the edges of the lesions, were identified for 
measurement of ADC values on transverse ADC maps. 
In case of visible tumors in multiple slices on the ADC 
map, ROIs were placed on each slice; from base to top 
of tumor. Among all slices minimum ADC value was 
adopted to statistic anlysis. In case of multiple tumors in 
one slice, ADC value of all tumors was measured, mini-
mum ADC value was then analyzed. ROIs were set to 
be at least 20 mm2 in order to minimize the influence of 
potential motion artifacts (Fig. 3).
Statistical analysis
Differences in ADC values according to T stage or ly were 
assessed using the Mann–Whitney U test. In addition, 
differences in ADC values according to INF or Grade 
were Scheffe test. Predictive accuracy was assessed using 
area under the receiver operating characteristics curve. 
All P values  <  0.05 were considered statistically signifi-
cant. R version 3.0.2 was used for all statistical analyses.
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